Headquarters
4 E 70TH ST APT 9A, NEW YORK, NY 10021-5151, US
NEW YORK, NY, US
EPITOR THERAPEUTICS, INC.
From the company
Epitor Therapeutics is advancing the next generation of epigenetic editors to treat diseases with high unmet need. Its optimized technology uses CRISPR-Cas to target specific genes and modulate gene expression without editing underlying DNA, and can target any organ of interest. The company unveiled CasNano, a compact, all-in-one CRISPR/Cas for single AAV therapies, at the American Society of Gene & Cell Therapy Annual Meeting.
Products & services offered
Facilities
Send your requirements
Quantities, certifications, and timing.